Pharmaceutical Technology - May 2021

Pharmaceutical Technology - Biologics and Sterile Drug Manufacturing - May 2021

Issue link: https://www.e-digitaleditions.com/i/1373953

Contents of this Issue

Navigation

Page 25 of 63

www.eppendorf.com/biofl o720 * BioFlo 720 is not a medical device as defi ned by the Food and Drug Administration or other regulatory authorities. Thermo Scientifi c TM and HyPerforma TM are trademarks of Thermo Fisher Scientifi c Inc, USA. Eppendorf ® , the Eppendorf Brand Design, and BioBLU ® are registered trademarks of Eppendorf AG, Germany. BioFlo ® is a registered trademark of Eppendorf, Inc, USA. All rights reserved, including graphics and images. Copyright © 2021 by Eppendorf AG. Scale Up! Seamlessly transition your mAbs process to the next level > Scalability: Compatible with the Thermo Scientifi c TM HyPerforma TM 5:1 Single-Use Bioreactors (S.U.B.) > E ciency: Intuitive software tools such as Auto Calibrate and Auto Infl ate > Application Driven: Documentation packages available to help assist quali- fi cation into cGMP biomanufacturing environments Many engineering parameters need to be considered to ensure a successful tech transfer from bench to pilot and production scale. E– cient and reliable scale-up of your monoclonal antibody process is no hurdle anymore with the BioFlo ® 720 bioreactor control system*. NEW: Bioprocess Control System

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - May 2021 - Pharmaceutical Technology - Biologics and Sterile Drug Manufacturing - May 2021